# Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption

## TL;DR

Aldosterone synthase inhibitors could revolutionize hypertension treatment but face adoption barriers like cost and access.

## Contribution

The paper discusses the potential and challenges of aldosterone synthase inhibitors in treating uncontrolled hypertension.

## Key findings

- Aldosterone synthase inhibitors show robust blood pressure reductions.
- Cost and access may hinder the widespread adoption of these inhibitors.

## Abstract

Despite many antihypertensive options, uncontrolled hypertension remains pervasive. Aldosterone synthase inhibitors show robust blood pressure reductions and have the potential to reshape hypertension treatment, though cost and access may impact broad adoption.

In this Perspective, Luke Laffin and Steven Nissen discuss the promise and challenges of aldosterone synthase inhibitors as the next breakthrough in the treatment of uncontrolled hypertension, the number one risk factor for cardiovascular disease.